Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines

Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines

The rapid spread, severity, and lack of specific treatment for COVID-19 resulted in hasty drug repurposing. Conceptually, trials of antivirals were well-accepted, but twentieth century antimalarials sparked an impassioned global debate. Notwithstanding, antiviral and immunomodulatory effects of amin...

Full description

Bibliographic Details
Main Authors: Joana Vitte, Moïse Michel, Soraya Mezouar, Aïssatou Bailo Diallo, Asma Boumaza, Jean-Louis Mege, Benoit Desnues
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Immunology
Subjects:
COVID-19
SARS-CoV-2
chloroquine
hydroxychloroquine
immune modulation
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.02159/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2020.02159/full

Similar Items